Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers

Pharmacological Reports

Volumn 58, Issue 5, 2006, Pages 692-699

  Suleyman, Halis ^a   Halici, Zekai ^a   Hacimuftuoglu, Ahmet ^a   Gocer, Fatma ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Adrenal glands; Adrenalectomy; Ca channel blockers; Carrageenan; Inflammation

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; CALCIUM CHANNEL BLOCKING AGENT; CARRAGEENAN; DICLOFENAC; HORMONE; LACIDIPINE; NICARDIPINE;

ADRENAL GLAND; ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; GRANULOMA; HORMONE ACTION; INFLAMMATION; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; RAT;

EID: 33751015444     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Abdollahi M, Nikfar S, Abdoli N: Potentiation by nitric oxide synthase inhibitor and calcium channel blocker of aspartame-induced antinociception in the mouse formalin test. Fundam Clin Pharmacol, 2001, 15, 117-123.
2. Abernethy DR, Schwartz JB: Calcium-antagonist drugs. N Engl J Med, 1999, 341, 1447-1457.
3. Agelaki S, Tsatsanis CH, Gravanis A, Margioris AN: Corticotropin-Releasing Hormone augments proinflammatory cytokin production from macrophages in vitro and in lipopolisaccharide-induced endotoxin shock in mice. Infect Immun, 2002, 70, 6068-6074.
4. Al-Tuwaijri AS, Mustafa AA: Verapamil enhances the inhibitory effect of diclofenac on the chemiluminescence of human polymorphonuclear leucocytes and carrageenan-induced rat's paw eadema. Int J Immunopharmacol, 1992, 14, 83-93.
5. Bemauer W, Heikura M: Untersuchungen ober die corticosteron seloretion bei katten nach verabreichung von Oxyphenbutazon. Med Pharmacol Exp, 1967, 16, 17-24.
6. Ben-Sreti MM, Gonzalez JP, Sewell RD: Effects of elevated calcium and calcium antagonists on 6, 7-benzomorfaninduced analgesia. Eur J Pharmacol, 1983, 75, 385-390.
7. Bilici D, Akpinar E, Gürsan N, Özbakis Dengiz G, Bilici S, Altas S: Protective effect of T-type calcium channel blocker in histamine-induced paw inflammation in rat. Pharmacol Res, 2001, 44, 527-531.
8. Campos MM, Mata LV, Calixto JB: Expression of BI kinin receptors mediating paw eadema and formalin-induced nociception. Modulation by glucocorticoids. Can J Physiol Pharmacol, 1995, 73, 812-819.
9. Carnevale KA, Cathcart MK: Calcium-independent phospholipase A2 is required for human monocyte chemotaxis to monocyle chemoattractant protein 1. J Immunol, 2001, 167, 3414-3421.
10. Chand N, Pillar J, Diamantis W, Sofia RD: In vitro inbibiton of allergic histamine release by calcium antagonists. Eur J Pharmacol, 1985, 107, 353-358.
11. Chaudhuri AKN, Karmakar S, Rey D, Pal S, Pal M, Sen T: Anti-inflammnatory activity of Indian black tea (Sikkim variety). Pharmacol Res, 2005, 51, 169-175.
12. Chow FS, Jusko WJ: Immunosuppresive interactions among calcium channel antagonists and selected corticosteroids and macrolides using human whole blood lymphocytes. Drug Metab Pharmacokinet, 2004, 19, 413-121.
13. De Souza AP, Tanowitz HB, Chandra M, Shtutin V, Weiss LM Morris SA, Factor SM, Huang H et al: Effects of early and late verapamil administration on the development cardiomyopathy in experimental chronic trypanosoma cruzi (Brazil strain) infection. Parasitol Res, 2004, 92, 496-501.
14. El-Bizri N, Bkaily G, Wang S, Jacques D, Regoli D, D'Orleans-Juste P, Sukarieh R: Bradykinin induced a positive chronotropic effect via stimulation of T-and L-type calcium currents in heart cells. Can J Physiol Pharmacol, 2003, 81, 247-258.
15. Elferink JG, Boonen GJ, Koster BM: The role of calcium in neutrophil migration: the effect of calcium and calcium-antagonists in electroporated neutrophils. Biochem Biophys Res Commun, 1992, 182, 864-869.
16. Fansa I, Gol MK Nisanoglu. V, Yavas S, Iscan Z, Tasdemir O: Does diltiazem inhibit the inflammatory response in cardiopulmonary bypass? Med Sci Monit, 2003, 9, 48-54.
17. Gamache DA, Povlishock JT, Ellis EF: Carragenan induced brain inflammation. J Neurosurg, 1986, 65, 679-685.
18. Goulding NJ: The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus. Curr Opin Pharmacol, 2004, 4, 629-636.
19. Gupta M, Mazumdar UK, Sivakumar T, Vamsi MLM, Karki SS, Sambathkumar R, Manikandan L: Evaluation of anti-inflammatory activity of chloroform extract of Bryonia Laciniosa in experimental animal models. Biol Pharm Bull, 2003, 26, 1342-1144.
20. Guyton AC, Hall JE: Textbook of Medical Physiology, 10th edn. WB Saunders, Philadelphia, 2001, 869-884.
21. Gürdal H, Sara Y, Tulunay FC: Effect of calcium channel blokers on formalin-induced nociception and inflammation in rats. Pharmacology, 1992, 44, 290-296.
22. Habashy RR, Abdel-Naim AB, Khalifa AE, Al-Azizi MM: Anti-inflammatory effects of jojoba liquid wax in experimental models. Pharmacol Res, 2005, 51, 95-105.
23. Higgins AJ: The biology pathophysiology and control of eicosanoids in inflammation. J Vet Pharmacol Ther, 1985, 8, 1-8.
24. Hosseinzadeh H, Ramezani M, Salmani G: Antinociceptive, antiinflammatory and acute toxicity effects of Zataria Multiflora Boiss extracts in mice and rats. J Ethnopharmacol, 2000, 73, 379-385.
25. Ishikawa J, Ohga K, Yoshino T, Takezawa R, Ichikawa A, Kubota H, Yamada T: A pyrazole derivative, YM-58483, potently inhibits store-operated sustained Ca influx and IL-2 production in T lymphocytes. J Imummnol, 2003, 4441-4449.
26. Jukema JW van der Hoorn JW: Amlodipin and atorvastatin in atherosclerosis. Exp Opin Pharmacother, 2004, 5, 459-468.
27. Kataoka C, Egashira K, Ishibashi M, Inoue S, Ni W, Hiasa K, Kitamoto S et al: Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis Am J Physiol Heart Circ Physiol, 2004, 286, 768-774.
28. Kouoh F, Gressier B, Dine T, Luyckx M, Brunet C, Ballester L, Cazin JC: Antioxidant effects and anti-elastase activity of the calcium antagonist nikardipine on activated human and rabbit neutrophils - a potential anti-atherosclerotic property of calcium antagonists? Cardiovasc Drugs Ther, 2002, 16, 515-520.
29. Leslie CC: Proporties and regulation of cytosolic phospholipase A2. J Biol Chem, 1997, 272, 16709-16712.
30. Linehan JD, Kolios G, Valatas V, Robertson DA, Westwick J: Effect of corticosteroids on nitric oxide production in inflammatory bowel disease: are leucocytes the site of action? Am J Physiol Gastrointest Liver Physiol, 2005, 288, 261-267.
31. Livingston A: Mechanism of action of nonsteroidal anti-inflamatory drugs. Vet Clin North Am Small Anim Pract, 2000, 30, 773-781.
32. Maling HM, Webster ME, Williams MA, Saul W, Anderson W Jr: Inflammation induced histamine, serotonin, bradykinin and compound 48-80 in the rat: antagonist and mechanisms of action. J Pharmacol Exp Ther, 1974, 191, 300-310.
33. Martinez LL, Aparecida De Oliveira M, Fortes ZB: Influence of verapamil and diclofenac on leukocyte migration in rats. Hipertension, 1999, 34, 997-1001.
34. Marzocco S, Di Paola R, Serraino I, Sorrentino R, Meli R, Mattaceraso G, Cuzzocrea S et al: Effect of methyl-guanidine in carrageenan-induced acute inflammation in the rats. Eur J Pharmacol, 2004, 484, 341-350.
35. Mohler III ER, Sorensen LC, Ghali LK, Schocken DD, Willis PW, Bowers JA et al.: Role of cytokines in the mechanism of action of amlodipine: the PRAISE heart failure trial. Prospective Randomized Amlodipine Survival Evaluation. J Am Coll Cardiol, 1997, 30, 35-41.
36. Nacife VP, Soeiro Mde N, Gomes RN, D'Avila H, Castro-Faria Neto HC, Meirelles Mde N: Morphological and biochemical characterization of macrophages activated by carrageenan and lipopolysaccharide in vivo. Cell Struct Funct. 2004, 29, 27-34.
37. Neto AG, Costa JMLC, Belati CC, Vinholis AHC, Possebom LS, Da Silva Filho AA, Cunha WR et al.: Analgesic and antiinflammatory activity of a crude root extract of Pfaffia glomerata (Spreng) Pedersen. J Ethnopharmacol, 2005, 96, 87-91.
38. Opie LH: Pharmacological differences between calcium antagonists. Eur Heart J, 1997, 18, 71-79.
39. Pitt B: Diversity of calcium antagonists. Clin Ther, 1997, 19, 3-17.
40. Panthong A, Kanjanapothi D, Taesotikul T, Phankummoon A, Panthong K, Reutrakul V: Antiinflammatory activity of methanolic extracts from Ventilago harmandiana Pierre. J Ethnopharmacol, 2004, 91, 237-242.
41. Ramprasath VR, Shanthi P, Sachdanandam P: Anti-inflammatory effect of Semecarpus anacardium Linn. Nut extract in acute and chronic inflammatory conditions. Biol Pharm Bull, 2004, 27, 2028-2031.
42. Serhan CN: Novel omega-3 derived local mediators in anti-inflammation and resolution. Pharmacol Ther, 2005, 105, 7-21.
43. Seth SD, Seth S: Calcium channels and calcium channel blockers. Indian J Physiol Pharmacol, 1991, 35, 217-231.
44. Singh BN, Josephson MA: Clinical pharmacology, pharmacokinetics and hemodynamic effects of nicardipine. Am Heart J, 1990, 119, 427-434.
45. Sirmagul B, Kilic FS, Batu O, Erol K: The effects of verapamil on stres-and histamine-induced gastric lesions in rats. Methods Find Exp Clin Pharmacol, 2004, 26, 763-767.
46. Slowik A Turaj W, Pankiewicz J, Dziedzic T, Szermer P, Szczudlik A: Hypercortisolemia in acute stroke is related to the inflammatory response. J Neurol Sci, 2002, 196, 27-32.
47. Suleyman H, Demircan B, Karagoz Y, Oztasan N, Suleyman B: Anti-inflammatory effects of selective cox-2 inhibitors. Pol J Pharmacol, 2004, 56, 775-780.
48. Suleyman H, Demirezer LO, Kuruuzum A, Banoglu ZN, Gocer F, Ozbakis G, Gepdiremen A: Antiinflammatory effect of the aqueous extract from Rumex patientia L. roots. J Ethnopharmacol, 1999, 65, 141-148.
49. Takeuchi A, Kobayashi K, Yukiyama Y, Chihara T, Matsuta K, Hashimoto A: Role of protease, protease inhibitor complexes in inflammation. Int Tissue React, 1984, 6, 1-8.
50. Vajja BN, Juluri S, Kumari M, Kole L, Chakrabarti R, Joshi VD: Lipopolysarcharide-induced paw edama. model for detection of cytokine modulating anti-inflammatory agent. Int Immunopharmacol, 2004, 4, 901-909.
51. Weissmann G: Prostaglandins as modulators rather than mediators of inflammation. J Lipid Mediat, 1993, 6, 275-286.
52. Zhou MS, Maimes EA, Raij L: Inhibiton of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens, 2004, 17, 167-171.